CJC-1295 without DAC + Ipamorelin
This blend names CJC1295 without DAC and Ipamorelin. It is distinct from either standalone product and from CJC-1295 with DAC.
Reviewed September 2026
- Residues
- Multiple components. not applicable: A single residue count is not defined for a mixture; component counts must not be summed into a fictitious peptide.
- Average mass
- Mixture-dependent. not applicable: There is no single molecular mass for this blend. Component molecular masses are separate properties, not a summed or arbitrary average blend mass.
- pI
- Not applicable. not applicable: A mixture has no unique single-peptide pI. Component pI values, mixture electrophoretic behavior and solution pH are distinct.
Reference details
| Residues | Multiple components |
|---|---|
| Average mass | Mixture-dependent |
| pI | Not applicable |
| Research area | Growth hormone, Multi-component blends |
|---|
Property basis and sources
These describe the reference compound or formulation, not identification or testing of the supplied lot.
Multi-component blend as designated by the reference title; not one covalently connected peptide. Component identity, proportions, salts and compatibility are not verified by component papers.
- Residues: Multiple components (not applicable). A single residue count is not defined for a mixture; component counts must not be summed into a fictitious peptide. Residues source 1
- Average mass: Mixture-dependent (not applicable). There is no single molecular mass for this blend. Component molecular masses are separate properties, not a summed or arbitrary average blend mass. Average mass source 1
- pI: Not applicable (not applicable). A mixture has no unique single-peptide pI. Component pI values, mixture electrophoretic behavior and solution pH are distinct. pI source 1
Reference scope and linked records
Reference type: Multi-component blend.
This is a research-reference entry, not a product certificate, treatment recommendation or administration guide. The sources below describe their own materials and methods. Catalogue identity, lot testing and clinical evidence are separate questions.
Catalogue context: CJC1295 (Without DAC) + Ipamorelin. The product retains its own name and specification; this link does not certify equivalence to published study material.
Related references
Sources and their scope
- hGRF1-29-albumin bioconjugates: identification of CJC-1295. This paper concerns albumin-binding CJC-1295 and is cited for contrast and context, not as evidence for this without-DAC blend or as an Aminos lot certificate.
- Ipamorelin, the first selective growth hormone secretagogue. Source for the chemistry or study context discussed above; not an Aminos lot certificate.
Source check: 26 September 2026. This is an editorial source check, not a claim of independent clinical or laboratory review.
About CJC-1295 without DAC + Ipamorelin
Identity and context
The catalogue names these components: CJC1295 without DAC, Ipamorelin. This is a mixture reference, not a new single molecule. The displayed total blend amount does not specify the individual ingredient amounts or establish their ratio.
Reference classification
Multi-component blend. The linked catalogue product is CJC1295 (Without DAC) + Ipamorelin. This reference does not independently authenticate the material supplied.
Storage and handling
Analytical specification
Obtain a formulation identifying every component, its individual amount, chemical form and the basis of the total amount. Ask for mixture-specific identity, compatibility and stability evidence; separate ingredient certificates alone cannot establish the finished formulation.
Storage and experimental handling
Use the documented conditions for the actual chemical form and preparation. No universal storage temperature, expiry or solution shelf life is assigned here. Follow the lot documentation, safety data sheet and validated laboratory protocol; this page is not a reconstitution or administration guide.
Research evidence
| Area | Summary | Evidence |
|---|---|---|
| What the source examines | The linked component references explain each named identity and the scope of its published evidence. The selected primary sources study defined components or specified research preparations; their inclusion is not evidence that the Aminos mixture was tested. A component mechanism does not demonstrate compatibility or synergy in a mixture. | Source context |
| What cannot be inferred | No mixture-specific primary evidence or lot-specific composition report was verified for this catalogue formulation. No clinical benefit, combined potency or universal stability is assigned. | Evidence limits |
References
Sources used for the data on this page, checked September 2026.
- hGRF1-29-albumin bioconjugates: identification of CJC-1295This paper concerns albumin-binding CJC-1295 and is cited for contrast and context, not as evidence for this without-DAC blend or as an Aminos lot certificate.
- Ipamorelin, the first selective growth hormone secretagoguePrimary source for the reference discussion; not lot-specific product evidence.
Reference information only. This page describes the chemistry and published research context of a laboratory compound. Nothing here is medical or dosing advice. Aminos compounds are for laboratory research use only and are not medicines.